Citius Pharmaceuticals Inc (CTXR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8490 -0.0249 (-2.85%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8500 +0.0010 (+0.12%) 18:13 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,426 | -32,543 | -33,641 | -23,054 | -17,548 |
| Depreciation Amortization | 210 | 194 | 180 | 165 | 152 |
| Income taxes - deferred | 576 | 576 | 576 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,000 | 1,762 | -112 | -579 | -857 |
| Other Working Capital | -1,685 | -4,006 | 240 | -2,717 | -867 |
| Other Operating Activity | 10,124 | 4,957 | 4,396 | 1,936 | 2,189 |
| Operating Cash Flow | $-28,201 | $-29,060 | $-28,361 | $-24,250 | $-16,931 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -7 | -2 |
| Other Investing Activity | -5,000 | 0 | 0 | -40,000 | 0 |
| Investing Cash Flow | $-5,000 | $N/A | $N/A | $-40,007 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 165 |
| Common Stock Issued | 13,804 | 13,830 | N/A | 102,193 | 22,734 |
| Other Financing Activity | -3,831 | 0 | 0 | 18,278 | 0 |
| Financing Cash Flow | $9,972 | $13,830 | $N/A | $120,471 | $22,898 |
| Beginning Cash Position | 26,481 | 41,712 | 70,073 | 13,860 | 7,894 |
| End Cash Position | 3,252 | 26,481 | 41,712 | 70,073 | 13,860 |
| Net Cash Flow | $-23,229 | $-15,231 | $-28,361 | $56,213 | $5,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,201 | -29,060 | -28,361 | -24,250 | -16,931 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -2 |
| Free Cash Flow | -28,201 | -29,060 | -28,361 | -24,257 | -16,933 |